⚠ COVID-19 INFORMATION: Resources, Vaccine Information
Research InnovationPublications Fenfluramine: New Treatment for Seizures in Dravet Syndrome
Pierce, J. G.; Mithal, D. S.
Pediatr Neurol Briefs. 2020 Mar 20; 34:8
Investigators for the FAiRE DS Study Group assessed the efficacy and safety of Fenfluramine for treating seizures in patients less than 18 y.o. with Dravet Syndrome in an international double-blind, placebo-controlled clinical trial. A total of 119 patients (mean age 9.0 y, 54% male) were enrolled in the study.
